New Current Report Filed with the SEC Relating to Statement that Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review Should Not Be Relied Upon: 8-K – Sagent Pharmaceuticals, Inc. (0001369786) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) relating to a statement that certain of the company’s previously-issued financial statements or a related audit report or completed interim review should not be relied upon by investors or other interested parties. Details of the current report are:

8-K – Sagent Pharmaceuticals, Inc. (0001369786) (Filer)
Filed: 2016-02-16 AccNo: 0001193125-16-463896 Size: 232 KB

Item 2.02: Results of Operations and Financial Condition

Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Item 9.01: Financial Statements and Exhibits
Filing Date: 2016-02-16T07:35:30-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1369786/000119312516463896/0001193125-16-463896-index.htm